TTRX
Turn Therapeutics
$7.78
−$0.76 (−8.9%)Jul 27, 2026
Key metrics
The numbers that frame TTRX today
- Market cap
- $231.75M
- P/E (TTM)
- -60.4
- ROIC
- -304.2%
- Div yield
- 0%
- Debt / equity
- 1.0
Growth
Revenue and earnings trend for TTRX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about TTRX
Is Turn Therapeutics a good buy?
Hold. There is not enough rank data to make a clear call.
What is the market capitalization of TTRX?
Turn Therapeutics's market capitalization is $231.75M.
What is the P/E ratio for TTRX stock?
Turn Therapeutics's current P/E ratio is -60.4.
Does TTRX stock pay dividends?
Turn Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TTRX?
Turn Therapeutics's Debt / Equity ratio is 0.98.